Released Jan 29, 2014, after the close
10-K filed Jan 29, 2014, 90 days after period end · 0001354488-14-000379
Q4 2013 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income$1.22M$1.22M derived+13.3% vs Q4 2012−2.2% vs Q3 2013
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$3,165,011+20.3%
Operating Incomederived$1,500,271+9.3%
Operating Cash Flowderived$2,973,278+95.4%
Free Cash Flowderived$2,929,289+96.6%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures |
|---|---|---|---|
| Net Income | $1.22M | $1.08M | $824.43K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pharma-Bio Serv, Inc. · CIK 1304161 · Engraved from SEC EDGAR